Position in SLDB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$655,884
-$623,014 QoQ
Shares Held
91,095
-59.8% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLDB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in SLDB
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $655,884 | 91,095 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,278,898 | 226,755 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,450,649 | 397,188 | Shares | Sole | 2025-11-13 | |
| 2021-12-31 | $213,144 | 121,797 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $286,149 | 119,728 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,660 | 727 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $8,012 | 1,449 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $10,983 | 1,449 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,465 | 722 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $35,546 | 14,873 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||